Offer was a 29% increase to Kite's closing price on Friday....
I've read that this is a new class of drug but to be used in the field on oncology and will be used with other immunotherapies.
Hoping that this is a good sign for Cavatak and VLA and there is still a huge appetite for cancer therapies!
- Forums
- ASX - By Stock
- Gilead buys Kite Pharma for $11.9 BN
Offer was a 29% increase to Kite's closing price on Friday.......
-
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online